PC12 - State Opioid Treatment Authorities' Meeting (Closed Session for State and Federal Officials)

Sunday, May 19, 2024

9:00 AM – 4:00 PM PST

Location: Celebrity 6

CE: 6.0

Pre-Conference Speaker(s)

Nichole W. Smith, MHSA (she/her/hers)

Branch Chief
SAMHSA/CSAT/Division of Pharmacologic Therapies
Rockville, Maryland
Tracy Weymouth, MSW, LADC

Accreditation Body Liaison
SAMHSA/CSAT/DPT
Rockville, Maryland
PJ

Patti Juliana, PhD (she/her/hers)

Director, Division of Pharmacologic Therapies
Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration
South Salem, New York
Yngvild Olsen, MD, MPH (she/her/hers)

Center Director
SAMHSA/CSAT
Rockville, Maryland

Pre-Conference Planner(s)

Nichole W. Smith, MHSA (she/her/hers)

Branch Chief
SAMHSA/CSAT/Division of Pharmacologic Therapies
Rockville, Maryland

Pre-Conference Speaker(s)

Belinda M. Greenfield, PhD (she/her/hers)

Public Health Advisor
SAMHSA, CSAT, DPT
Tenafly, New Jersey

Presentation Summary: The purpose of this meeting is to improve alignment of federal goals and state and local needs for people enrolled in OTPs and for the OTP providers. The revisions of 42 CFR Part 8 requires that CSAT reviews the final version of the regulations with the SOTAs and that CSAT and the SOTAs work together to determine implications of the revisions for the respective states. To optimize implementation of 42 CFR Part 8, this meeting will consider ways in which CSAT might best support and enhance State efforts. All SOTAs are requested to attend.

Learning Objectives:

At the completion of this activity, participants will:

Describe their role in the context of federal and state systems.
Recall CSAT’s paradigm for treatment under the revised Federal regulations and explain its underlying values.
Identify a regulatory area that might be impacted by the revised regulations and discuss ways in which they might facilitate OTP implementation of the revisions.